AlloVir Statistics
Total Valuation
AlloVir has a market cap or net worth of $49.21 million. The enterprise value is -$69.08 million.
Market Cap | 49.21M |
Enterprise Value | -69.08M |
Important Dates
The next estimated earnings date is Monday, May 12, 2025, before market open.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AlloVir has 5.02 million shares outstanding.
Current Share Class | 5.02M |
Shares Outstanding | 5.02M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 15.29% |
Owned by Institutions (%) | 15.05% |
Float | 1.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.43 |
P/TBV Ratio | 0.43 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.63
Current Ratio | 22.63 |
Quick Ratio | 22.58 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -45.37% and return on invested capital (ROIC) is -24.11%.
Return on Equity (ROE) | -45.37% |
Return on Assets (ROA) | -22.33% |
Return on Invested Capital (ROIC) | -24.11% |
Return on Capital Employed (ROCE) | -48.77% |
Revenue Per Employee | n/a |
Profits Per Employee | -$9.79M |
Employee Count | 6 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.24% in the last 52 weeks. The beta is 0.62, so AlloVir's price volatility has been lower than the market average.
Beta (5Y) | 0.62 |
52-Week Price Change | -45.24% |
50-Day Moving Average | 9.78 |
200-Day Moving Average | 14.77 |
Relative Strength Index (RSI) | 50.87 |
Average Volume (20 Days) | 8,869 |
Short Selling Information
The latest short interest is 64,613, so 1.29% of the outstanding shares have been sold short.
Short Interest | 64,613 |
Short Previous Month | 59,532 |
Short % of Shares Out | 1.29% |
Short % of Float | 3.73% |
Short Ratio (days to cover) | 26.44 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -55.26M |
Pretax Income | -179.66M |
Net Income | -58.77M |
EBITDA | -54.86M |
EBIT | -55.26M |
Earnings Per Share (EPS) | -$11.73 |
Balance Sheet
The company has $118.29 million in cash and n/a in debt, giving a net cash position of $118.29 million or $23.58 per share.
Cash & Cash Equivalents | 118.29M |
Total Debt | n/a |
Net Cash | 118.29M |
Net Cash Per Share | $23.58 |
Equity (Book Value) | 113.31M |
Book Value Per Share | 22.60 |
Working Capital | 113.31M |
Cash Flow
Operating Cash Flow | -67.71M |
Capital Expenditures | n/a |
Free Cash Flow | -67.71M |
FCF Per Share | -$13.50 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AlloVir does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -119.42% |
FCF Yield | -137.58% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 16, 2025. It was a reverse split with a ratio of 0.0434783:1.
Last Split Date | Jan 16, 2025 |
Split Type | Reverse |
Split Ratio | 0.0434783:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |